Access to Medicine Versus Test Data Exclusivity Safeguarding Flexibilities Under International Law /
| 第一著者: | |
|---|---|
| 団体著者: | |
| 要約: | XVI, 256 p. 78 illus., 56 illus. in color. text |
| 言語: | 英語 |
| 出版事項: |
Berlin, Heidelberg :
Springer Berlin Heidelberg : Imprint: Springer,
2016.
|
| 版: | 1st ed. 2016. |
| シリーズ: | Munich Studies on Innovation and Competition,
4 |
| 主題: | |
| オンライン･アクセス: | https://doi.org/10.1007/978-3-662-49655-8 |
| フォーマット: | 電子媒体 図書 |
目次:
- Introduction
- Test Data Exclusivity: Raison d'être
- Test Data Exclusivity and Art 39(3) TRIPS
- Test Data Exclusivity in the US and the EU
- Index of Data Exclusivity and Access (IDEAS) - Free Trade Agreements
- Index of Data Exclusivity and Access (IDEAS) - National Laws
- Test Data Exclusivity in FTAs and Access to Originator Pharmaceuticals
- Conclusions and Recommendations.